Imatinib Mesylate is used to treat chronic myelogenous leukemia, gastrointestinal stromal tumors and a number of other malignancies. It is sold under the brand names Gleevec. Reference standards of Imatinib Mesylate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Imatinib Mesylate - API Standards [catalogue_number] => PA 09 28000 [category_ids] => ,80,71,78,70,82,117, [chemical_name] => [weight] => 589.71 [form] => C30H35N7O4S [cas] => 220127-57-1 [pslug] => 220127-57-1-imatinib-mesylate-api-pa0928000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 37299 [offers_product_code] => PA 09 28000 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 09 28000
CAS :
Molecular Formula : C30H35N7O4S
Molecular Weight : 589.71
stdClass Object ( [pname] => Imatinib Mesylate - Impurity C [catalogue_number] => PA 09 28030 [category_ids] => ,76,78,70,82,117, [chemical_name] => [weight] => 479.58 [form] => C28H29N7O [cas] => 404844-02-6 [pslug] => 404844-02-6-imatinib-mesylate-impurity-c-pa0928030 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 37302 [offers_product_code] => PA 09 28030 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 09 28030
Molecular Formula : C28H29N7O
Molecular Weight : 479.58
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
